
    
      SAFE-PROTECT trial is composed of Roll-in group, small-size group and RCT group. This trial
      is planned to conduct in about 20 sites from China.

      Roll-in group plans to enroll at most 3 subjects each site to implant experimental device for
      exploration and observation.

      RCT group plans to enroll no less than 210 subjects who meet the inclusion/exclusion
      criteria, and 1:1 randomly allocated to experimental arm or comparator arm.
    
  